'Exciting breakthrough': COVID-19 drug trial to take place in Edmonton
Trials for a Canadian-developed COVID-19 treatment are set to begin at the University of Alberta.
The study will evaluate the safety and efficacy of the drug Apabetalone as a potential oral medication to help prevent severe infection from COVID-19.
“It’s a pretty exciting breakthrough,” Donald McCaffrey, the president and CEO of Resverlogix, said.
The clinical program will test epigenetics on COVID-19 patients, including those who were sick with a variant strain.
“The genetics is the hardware, the epigenetics is the software. The science of learning to turn on or off various genes,” McCaffrey explained.
The drug has been in development for more than 20 years and when COVID-19 emerged, a group of universities began studying drugs already in production that could be repurposed to help fight COVID-19. Apabetalone ended up being “number two on the list,” according to McCaffrey.
“We do have a huge lead on the world in knowledge on this (protein) and how to remove it.”
The drug is an oral pill taken once in the morning and once at night. A total of 100 patients are expected to be enrolled over the coming week to take part in the trial at various sites in Canada and Brazil.
“By removing the bromodomain (BD2) and shutting down the ACE2 receptors, you’re greatly inhibiting the virus’s ability to reproduce,” McCaffrey shared.
'WE DO NOT CHANGE THE HUMAN DNA'
The average COVID-19 hospital stay right now is 11.9 days, McCaffrey told CTV News Edmonton. That stay increases up to 23 days if the patient has cardiovascular issues. He said the cost can range from $26,000 to $52,000 per patient receiving care.
“The goal is to show that we can remove the long hospital stays.”
McCaffrey said because of Apabetalone’s unique epigenetic mechanism, it has the ability to stop disease progression by regulating the “expression” of disease and inflammation-causing genes.
“We do not change the human DNA; it remains identical,” he said. “But, we do turn the genes on or off, and that has a huge therapeutic benefit for our patients.”
In addition to reducing the duration of the disease, the hope is that the drug will also potentially be able to protect those infected from the long-term effects of long-COVID.
'IT WILL BE EFFECTIVE'
Apabetalone would cost about $7 per pill and should be taken for two to three weeks, McCaffrey said.
If the trials are successful, the team's next step would be to apply for an emergency management application in Canada in June, and then in the U.S. about six months later, McCaffrey explained.
“The vaccine is the most important thing at the moment,” Dr. Noel Gibney, professor emeritus, critical care medicine at the U of A, added. “But, we know that even with vaccination, people with critically poor immune systems are still at risk. So, it really is important that we have other therapies.”
With years of data backing the science, efficacy and safety of the drug, McCaffrey is confident it could help “manage the real problem,” which he says is the “bottleneck” in hospitals.
“No matter what Greek alphabet we get hit with next, it will be effective against all future variants.”
With files from CTV News Edmonton’s Carlyle Fiset
CTVNews.ca Top Stories
Police arrest 3 Indian nationals in killing of B.C. Sikh activist Hardeep Singh Nijjar
Three people have been arrested and charged in the killing of B.C. Sikh activist Hardeep Singh Nijjar – as authorities continue investigating potential connections to the Indian government.
TD worst-case scenario more likely after drug money laundering allegations: analyst
TD Bank Group could be hit with more severe penalties than previously expected, says a banking analyst after a report that the investigation it faces in the U.S. is tied to laundering illicit fentanyl profits.
Human remains found in rural Sask. possibly a decade old, RCMP say
RCMP say human remains found in a rural area in central Saskatchewan may have been there for a decade or more.
2 charged after police find 'concerning and diverse' explosives at Manitoba home
Winnipeg police say they have arrested two people in their 20s after a large amount of explosives were found in a home outside of Winnipeg, Man.
Five areas Canada's foreign interference commissioner says needs more investigation
Commissioner Marie-Josee Hogue released her interim report examining foreign election interference on Friday. Here are five elements of the issue that Hogue says she needs to further probe before she can make conclusions or recommendations.
Drew Carey is never quitting 'The Price Is Right'
Drew Carey took over as host of 'The Price Is Right' and hopes he’s there for life. 'I'm not going anywhere,' he told 'Entertainment Tonight' of the job he took over from longtime host Bob Barker in 2007.
Police officer hit by driver of fleeing vehicle in Toronto
York Regional Police say they are continuing to search for a suspect in an auto theft investigation who was captured on video running over a police officer in Toronto last month.
Why your airfare may be getting more expensive
Skyrocketing airfare prices are linked to heightened competition and rising food and fuel, according to the CAA.
Canadian doctor concerned new weight-loss drug Wegovy may be used inappropriately
As Wegovy becomes available to Canadians starting Monday, a medical expert is cautioning patients wanting to use the drug to lose weight that no medication is a ''magic bullet,' and the new medication is meant particularly for people who meet certain criteria related to obesity and weight.